Yatharth Hospital Board Approves ₹3,150 Crore Preferential Issue to Rasmalai Ltd.
Yatharth Hospital approved a preferential issue of equity shares and warrants to Rasmalai Limited for up to ₹3,150 crore. The company also plans to increase its authorized share capital from ₹115 crore to ₹150 crore. An EGM is scheduled for October 15, 2026, to seek shareholder approval for these proposals.
The preferential issue of ₹3,150 crore represents a substantial capital infusion, which can significantly impact the company's financial structure, growth prospects, and potentially its market valuation. The issuance of new shares also affects the existing shareholding pattern.
The company is undertaking a significant fundraising exercise through a preferential issue, which is generally viewed positively as it can provide capital for growth and expansion. The increase in authorized share capital also indicates a forward-looking approach.
Yatharth Hospital & Trauma Care Services Limited announced that its Board of Directors, in a meeting held on September 17, 2026, approved a significant preferential issue of equity shares and warrants to Rasmalai Limited, a company incorporated in Cyprus. The total consideration for this issuance is up to ₹3,150 crore (INR 31,50,00,02,910.60).
This preferential issue includes up to 1,30,26,516 equity shares at an issue price of ₹985.17 per share, aggregating to ₹1,283.33 crore. Additionally, up to 1,89,47,664 warrants will be issued, each carrying the right to subscribe to one equity share at ₹985.17 per warrant. 25% of the warrant consideration will be paid upfront, with the remaining 75% payable upon exercise. The total post-issue shareholding of Rasmalai Limited is expected to be 24.87% on a fully diluted basis.
The Board also approved an increase in the company's authorized share capital from ₹115 crore to ₹150 crore, subject to shareholder approval. The Memorandum of Association will be amended accordingly. Furthermore, the Board approved the adoption of amended and restated Articles of Association, which will incorporate special rights for the investor and rights for the promoters, subject to shareholder approval.
An Extra-Ordinary General Meeting (EGM) has been convened for October 15, 2026, at 11 AM IST, to seek shareholder approval for the proposed increase in authorized share capital, the preferential issue, the amended Articles of Association, and special rights. The Board meeting commenced at 10:40 AM and concluded at 11:39 AM IST.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.